- Detection of HIV for Self-Testing, PAR-21-070 (https://grants.nih.gov/grants/guide/pa-files/PAR-21-070.html). The next application due date is March 17, 2022.
The purpose is to support high-risk, bi-phasic, milestone-driven research and early-stage development of innovative technologies designed to enable rapid self-testing assays to meet one or both of the following research objectives:- detecting HIV (RNA, DNA, protein or biomarker) at the earliest stage of initial infection, ideally less than 2 weeks post-infection; and/or
- detecting HIV rebound in treated individuals as early as possible following treatment interruption or loss of viral suppression by ART.
Proposed studies should emphasize innovation and exploratory research with a focus on qualitative or semi-quantitative HIV detection and assay development, and should include plans to obtain end-user input on assay performance and usability.
- Pilot award competition: Point-of-Care Technologies for HIV/AIDS in Low- and Middle-Income Countries (https://www.cimit.net/web/c-than/solicitations) through C-THAN, one of the four POCTRN centers supported by NIBIB and OAR (https://www.poctrn.org/). This is an annual solicitation for 1-year pilot projects focused on diagnostics or technologies related to HIV/AIDS, co-morbidities, or treatment monitoring.
Expressions of interest are due by February 28, 2022.
Applications must describe how the device/test is applicable to LMIC settings, the cost of POCT and disposables, and how the proposed project addresses one or more of the NIH OAR research priorities:- Reduce the Incidence of HIV, including supporting the development of safe and effective vaccines, microbicides, and pre-exposure prophylaxis.
- Develop Next-Generation HIV Therapies with improved safety and ease of use.
- Conduct Research Toward HIV Cure.
- Address HIV-Associated Comorbidities, Coinfections, and Complications through research designed to decrease and/or manage these conditions.
- Advance Cross-Cutting Areas of research in the basic sciences, behavioral and social sciences, epidemiology, implementation science, information dissemination, and research training.
Contact:
Diane Lawrence, Ph.D.
Program Officer, Pathogenesis and Basic Research Branch
Project Officer/COR, HIV Reagent Program (www.HIVReagentProgram.org)
Basic Science Program, Division of AIDS, NIAID
Telephone: 240-627-3202, Email: lawrencedi@niaid.nih.gov
--------------------------------------------------------------
Advancing Communication Strategies to Support Future HIV Vaccine Use
https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-22-170.html (R01)
https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-22-171.html (R21)
This RFA is co-sponsored by NIMH, NIDA, and NIH OBSSR. Applications are due May 10, 2022.
Contact:
Michael J. Stirratt, Ph.D.
National Institute of Mental Health (NIMH)
Telephone: 240-627-3875
Email: stirrattm@nih.gov
-----------------------------
The role of Epstein Barr virus (EBV) infection in Non-Hodgkin Lymphoma (NHL) and Hodgkin disease (HD) development with or without an underlying HIV infection (U01 Clinical Trial Optional). Here is the link: https://grants.nih.gov/grants/guide/pa-files/PAR-21-348.html
Contact:
Elizabeth L. Read-Connole, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-6190
Email: bconnole@mail.nih.gov
----------------------------
Full list of FOAs - DOC